ALB and metabolic dysfunction-associated steatotic liver disease: We used the following noninvasive methods to evaluate liver fibrosis: acoustic radiation force impulse (ARFI), the aspartate aminotransferase/platelet (AST/PLT) ratio index (APRI), the NAFLD score (which uses age, BMI, diabetes, AST/ALT ratio, platelet count, and albumin [20]), and the fibrosis 4 (FIB-4) score (calculated from age, AST, ALT, and platelet count [21,22]).